Blackrock Health Sciences Term Trust Form 4 insider transactions

BlackRock Health Sciences Term Trust's Portfolio Manager, Liu Xiang, reported vesting and cash settlement of phantom shares.

BlackRock Health Sciences Term Trust portfolio manager, Xie H Erin, reported the sale of common stock following the vesting and conversion of phantom shares.

A director at BlackRock Health Sciences Term Trust executed pre-planned sales of common stock totaling over 20,000 shares in December 2025.

Saba Capital Management, L.P. reports disposition of shares in BlackRock Health Sciences Term Trust (BMEZ) due to a change of control transaction.

Portfolio Manager Erin Xie H reports the acquisition and disposal of common stock and phantom shares in BlackRock Health Sciences Term Trust on January 31, 2025.

Portfolio Manager Kyle McClements reports acquisition and disposal of BlackRock Health Sciences Term Trust (BMEZ) common stock and phantom shares on January 31, 2025.

Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Term Trust, reports a transaction involving common stock and phantom shares on January 31, 2025.

Portfolio Manager Xiang Liu reports acquisition and disposal of BlackRock Health Sciences Term Trust common stock and phantom shares on January 31, 2025.

Saba Capital Management, L.P. reports increased ownership in BlackRock Health Sciences Term Trust (BMEZ) through recent stock purchases.

Saba Capital Management, a 10% owner of BlackRock Health Sciences Term Trust (BMEZ), has increased its holdings by purchasing 15,281 shares of common stock.

Christopher Accettella, a Portfolio Manager at BlackRock Health Sciences Term Trust, recently purchased 1,190 shares of common stock at $15.17 per share.

Saba Capital Management, a 10% owner of BlackRock Health Sciences Term Trust (BMEZ), reports purchasing additional shares, increasing their holdings.

Saba Capital Management, L.P. reports acquiring additional shares of BlackRock Health Sciences Term Trust (BMEZ), increasing its beneficial ownership.

Saba Capital Management, L.P. reports increased ownership in BlackRock Health Sciences Term Trust (BMEZ) through recent stock purchases.

Saba Capital Management, L.P. reports purchasing 300 shares of BlackRock Health Sciences Term Trust (BMEZ) at $15.73 per share, increasing their indirect holdings.

Saba Capital Management, a 10% owner of BlackRock Health Sciences Term Trust (BMEZ), has increased its holdings by purchasing 2,006 shares of common stock.

Saba Capital Management, along with Boaz Weinstein, reports an increase in their beneficial ownership of BlackRock Health Sciences Term Trust (BMEZ) common stock following a recent transaction.

Saba Capital Management, L.P. reports increased ownership in BlackRock Health Sciences Term Trust (BMEZ) through recent stock purchases.

Kyle McClements, a Portfolio Manager at BlackRock Health Sciences Term Trust, recently increased his holdings of the company's common stock through open market purchases.

Saba Capital Management, along with Boaz Weinstein, reports acquiring additional shares of BlackRock Health Sciences Term Trust, increasing their beneficial ownership.

Saba Capital Management, L.P. reports an increase in its holdings of BlackRock Health Sciences Term Trust (BMEZ) common stock.

Saba Capital Management, L.P. reports acquiring additional shares of BlackRock Health Sciences Term Trust (BMEZ), increasing its beneficial ownership.

Saba Capital Management, a 10% owner of BlackRock Health Sciences Term Trust (BMEZ), has increased its holdings by purchasing 13,781 shares of common stock.

Saba Capital Management, along with Boaz Weinstein, reports increased beneficial ownership of BlackRock Health Sciences Term Trust (BMEZ) common stock following recent purchases.

Saba Capital Management, along with Boaz Weinstein, reports acquiring additional shares of BlackRock Health Sciences Term Trust (BMEZ), increasing their beneficial ownership.

Saba Capital Management, L.P. has increased its holdings in BlackRock Health Sciences Term Trust (BMEZ) through recent purchases of common stock.